Logo image of REX

REX AMERICAN RESOURCES CORP (REX) Stock Fundamental Analysis

USA - NYSE:REX - US7616241052 - Common Stock

30.57 USD
+0.02 (+0.07%)
Last: 9/16/2025, 10:05:50 AM
Fundamental Rating

6

REX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 210 industry peers in the Oil, Gas & Consumable Fuels industry. REX has an excellent financial health rating, but there are some minor concerns on its profitability. REX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

REX had positive earnings in the past year.
In the past year REX had a positive cash flow from operations.
REX had positive earnings in each of the past 5 years.
Each year in the past 5 years REX had a positive operating cash flow.
REX Yearly Net Income VS EBIT VS OCF VS FCFREX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

With a decent Return On Assets value of 8.17%, REX is doing good in the industry, outperforming 79.52% of the companies in the same industry.
REX's Return On Equity of 10.56% is fine compared to the rest of the industry. REX outperforms 62.38% of its industry peers.
REX's Return On Invested Capital of 7.67% is fine compared to the rest of the industry. REX outperforms 67.62% of its industry peers.
The Average Return On Invested Capital over the past 3 years for REX is significantly below the industry average of 21.90%.
The 3 year average ROIC (6.75%) for REX is below the current ROIC(7.67%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 8.17%
ROE 10.56%
ROIC 7.67%
ROA(3y)7.34%
ROA(5y)6.43%
ROE(3y)9.47%
ROE(5y)8.27%
ROIC(3y)6.75%
ROIC(5y)6.3%
REX Yearly ROA, ROE, ROICREX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

With a Profit Margin value of 8.86%, REX perfoms like the industry average, outperforming 51.90% of the companies in the same industry.
REX's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 10.07%, REX is not doing good in the industry: 62.38% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of REX has grown nicely.
The Gross Margin of REX (14.29%) is worse than 67.62% of its industry peers.
In the last couple of years the Gross Margin of REX has grown nicely.
Industry RankSector Rank
OM 10.07%
PM (TTM) 8.86%
GM 14.29%
OM growth 3Y3.74%
OM growth 5Y115.56%
PM growth 3Y10.21%
PM growth 5Y38.58%
GM growth 3Y4.03%
GM growth 5Y23.89%
REX Yearly Profit, Operating, Gross MarginsREX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

9

2. Health

2.1 Basic Checks

REX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
REX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for REX has been reduced compared to 5 years ago.
There is no outstanding debt for REX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
REX Yearly Shares OutstandingREX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
REX Yearly Total Debt VS Total AssetsREX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

REX has an Altman-Z score of 7.24. This indicates that REX is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.24, REX belongs to the top of the industry, outperforming 91.90% of the companies in the same industry.
REX has a debt to FCF ratio of 0.35. This is a very positive value and a sign of high solvency as it would only need 0.35 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.35, REX belongs to the best of the industry, outperforming 92.38% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that REX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.01, REX belongs to the top of the industry, outperforming 83.81% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.35
Altman-Z 7.24
ROIC/WACC0.88
WACC8.7%
REX Yearly LT Debt VS Equity VS FCFREX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M 500M

2.3 Liquidity

REX has a Current Ratio of 8.45. This indicates that REX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of REX (8.45) is better than 95.24% of its industry peers.
A Quick Ratio of 7.80 indicates that REX has no problem at all paying its short term obligations.
REX has a better Quick ratio (7.80) than 95.71% of its industry peers.
Industry RankSector Rank
Current Ratio 8.45
Quick Ratio 7.8
REX Yearly Current Assets VS Current LiabilitesREX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

4

3. Growth

3.1 Past

The earnings per share for REX have decreased by -5.19% in the last year.
The Earnings Per Share has been growing by 54.06% on average over the past years. This is a very strong growth
The Revenue for REX has decreased by -18.20% in the past year. This is quite bad
The Revenue has been growing by 8.99% on average over the past years. This is quite good.
EPS 1Y (TTM)-5.19%
EPS 3Y4.1%
EPS 5Y54.06%
EPS Q2Q%-11.2%
Revenue 1Y (TTM)-18.2%
Revenue growth 3Y-6.05%
Revenue growth 5Y8.99%
Sales Q2Q%-1.79%

3.2 Future

REX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.03% yearly.
Based on estimates for the next years, REX will show a quite strong growth in Revenue. The Revenue will grow by 10.00% on average per year.
EPS Next Y-52.42%
EPS Next 2Y-4.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.32%
Revenue Next 2Y10%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
REX Yearly Revenue VS EstimatesREX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
REX Yearly EPS VS EstimatesREX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

REX is valuated reasonably with a Price/Earnings ratio of 9.29.
Compared to the rest of the industry, the Price/Earnings ratio of REX is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.27, REX is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 10.09, the valuation of REX can be described as reasonable.
The rest of the industry has a similar Price/Forward Earnings ratio as REX.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.77, REX is valued rather cheaply.
Industry RankSector Rank
PE 9.29
Fwd PE 10.09
REX Price Earnings VS Forward Price EarningsREX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

64.29% of the companies in the same industry are more expensive than REX, based on the Enterprise Value to EBITDA ratio.
REX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 52.68
EV/EBITDA 6.25
REX Per share dataREX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

REX has a very decent profitability rating, which may justify a higher PE ratio.
REX's earnings are expected to decrease with -4.03% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.17
EPS Next 2Y-4.03%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for REX!.
Industry RankSector Rank
Dividend Yield N/A

REX AMERICAN RESOURCES CORP

NYSE:REX (9/16/2025, 10:05:50 AM)

30.57

+0.02 (+0.07%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-25 2025-08-25/bmo
Earnings (Next)12-01 2025-12-01/bmo
Inst Owners88.43%
Inst Owner Change-3.69%
Ins Owners14.34%
Ins Owner Change3.49%
Market Cap505.32M
Analysts80
Price TargetN/A
Short Float %N/A
Short Ratio4.13
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.29%
Min Revenue beat(2)-2.79%
Max Revenue beat(2)3.38%
Revenue beat(4)2
Avg Revenue beat(4)2.08%
Min Revenue beat(4)-2.79%
Max Revenue beat(4)9.23%
Revenue beat(8)4
Avg Revenue beat(8)2.04%
Revenue beat(12)7
Avg Revenue beat(12)2.33%
Revenue beat(16)10
Avg Revenue beat(16)2.8%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 9.29
Fwd PE 10.09
P/S 0.79
P/FCF 52.68
P/OCF 8.02
P/B 0.94
P/tB 0.94
EV/EBITDA 6.25
EPS(TTM)3.29
EY10.76%
EPS(NY)3.03
Fwd EY9.91%
FCF(TTM)0.58
FCFY1.9%
OCF(TTM)3.81
OCFY12.46%
SpS38.69
BVpS32.45
TBVpS32.45
PEG (NY)N/A
PEG (5Y)0.17
Profitability
Industry RankSector Rank
ROA 8.17%
ROE 10.56%
ROCE 9.96%
ROIC 7.67%
ROICexc 15%
ROICexgc 15%
OM 10.07%
PM (TTM) 8.86%
GM 14.29%
FCFM 1.5%
ROA(3y)7.34%
ROA(5y)6.43%
ROE(3y)9.47%
ROE(5y)8.27%
ROIC(3y)6.75%
ROIC(5y)6.3%
ROICexc(3y)16.25%
ROICexc(5y)14.31%
ROICexgc(3y)16.25%
ROICexgc(5y)14.31%
ROCE(3y)8.77%
ROCE(5y)8.17%
ROICexcg growth 3Y-10.04%
ROICexcg growth 5Y127.29%
ROICexc growth 3Y-10.04%
ROICexc growth 5Y127.29%
OM growth 3Y3.74%
OM growth 5Y115.56%
PM growth 3Y10.21%
PM growth 5Y38.58%
GM growth 3Y4.03%
GM growth 5Y23.89%
F-Score5
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF 0.35
Debt/EBITDA 0.03
Cap/Depr 239.19%
Cap/Sales 8.35%
Interest Coverage 250
Cash Conversion 72.63%
Profit Quality 16.93%
Current Ratio 8.45
Quick Ratio 7.8
Altman-Z 7.24
F-Score5
WACC8.7%
ROIC/WACC0.88
Cap/Depr(3y)192.86%
Cap/Depr(5y)131.33%
Cap/Sales(3y)5.81%
Cap/Sales(5y)4.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.19%
EPS 3Y4.1%
EPS 5Y54.06%
EPS Q2Q%-11.2%
EPS Next Y-52.42%
EPS Next 2Y-4.03%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-18.2%
Revenue growth 3Y-6.05%
Revenue growth 5Y8.99%
Sales Q2Q%-1.79%
Revenue Next Year3.32%
Revenue Next 2Y10%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-11.53%
EBIT growth 3Y-2.54%
EBIT growth 5Y134.95%
EBIT Next Year3.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-77.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.83%
OCF growth 3Y-11.21%
OCF growth 5Y44.19%